Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome
A Mendelian randomization analysis study (209) detected that lowering LDL-C and PCSK9 protein levels by PCSK9 variants was relevant to an increase in CB, demonstrating that direct bilirubin is increased with the use of newer lipid-lowering therapies like the preprotein convertase chytokeratase/kexin type 9 (PCSK9), monoclonal antibody inhibitors: alirocumab and evolocumab, and hepatic PCSK9 siRNA inhibitor inclisiran
The plasmid system is relatively stable but has low cutting and editing efficiency, and continuous expression of Cas9 may increase off-target effects
The FDA still decides whether to follow the panel's advice
IMU-838, a Developmental DHODH inhibitor in phase II for autoimmune disease, shows anti-SARS-CoV-2 and broad-spectrum antiviral efficacy in vitro
doi: 10.1371/journal.pone.0057610 122 HanBMengXChenHChenLLiuXWangHet al